Report: Trump Administration Threatens To Withhold HIV Medication To Zambia Unless Minerals Deal Demands Are Met
By Owen Scott\The Independent Photos: YouTube Screenshots The Trump administration is considering cutting HIV relief to Zambia if the country fails to meet a list of demands, according to a new report. Key to those demands is the U.S. receiving more access to Zambia’s natural minerals, according to The New York Times. An estimated 1.3 million people in Zambia rely on antiretroviral medications, according to a study published in the National Library of Medicine. Forty-two percent of those drugs are provided through PEPFAR, the President’s Emergency Plan for AIDS Relief, a U.S. HIV/AIDS relief scheme. However, that assistance could be “significantly cut” as soon as May, according to a draft memo prepared for Secretary of State Marco Rubio by his department’s Bureau of African Affairs. “We will only secure our priorities by demonstrating willingness to publicly take support away from Zambia on a massive scale,” reads the memo, which was seen by the Times. READ MORE…
By Owen Scott\The Independent
Photos: YouTube Screenshots
The Trump administration is considering cutting HIV relief to Zambia if the country fails to meet a list of demands, according to a new report.

Key to those demands is the U.S. receiving more access to Zambia’s natural minerals, according to The New York Times.
An estimated 1.3 million people in Zambia rely on antiretroviral medications, according to a study published in the National Library of Medicine. Forty-two percent of those drugs are provided through PEPFAR, the President’s Emergency Plan for AIDS Relief, a U.S. HIV/AIDS relief scheme.
However, that assistance could be “significantly cut” as soon as May, according to a draft memo prepared for Secretary of State Marco Rubio by his department’s Bureau of African Affairs.
“We will only secure our priorities by demonstrating willingness to publicly take support away from Zambia on a massive scale,” reads the memo, which was seen by the Times. READ MORE…




